Lobbying client
TOLMAR, INC.
pharmaceutical company
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Filings
4
Filed by
2
Reported in-house
—
Reported by firms
$120,000
Filings
4 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
TARPLIN, DOWNS & YOUNG, LLC | $50,000 reported |
|
Registration 3rd Quarter 2026
|
TARPLIN, DOWNS & YOUNG, LLC | — reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | $70,000 reported |
|
Registration 3rd Quarter 2026
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| BROWNSTEIN HYATT FARBER SCHRECK, LLP | 1 | $70,000 |
| TARPLIN, DOWNS & YOUNG, LLC | 1 | $50,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medicare/Medicaid | MMM | 2 |
| Pharmacy | PHA | 2 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.